Bio-techne Corp. share price logo

Bio-techne Corp. Share Price

NASDAQ: TECH

Large Cap

$51.27

-1.94

(-3.65%)

as on

Bio-techne Corp. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $50.76
    $52.96
    downward going graph

    0.99%

    Downside

    3.30%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $46.01
    $80.95
    downward going graph

    10.26%

    Downside

    57.89%

    Upside

    downward going graph

Bio-techne Corp. share price movements today

Previous Close
$53.21
Open
$52.96
Volume
1.5M
Day's Low - High
$50.76 - $52.96
52 Week Low - High
$46.01 - $80.95

Bio-techne Corp. Historical Returns

1 Month Return
-6.31 %
3 Month Return
+ 1.46 %
1 Year Return
-31.35 %
3 Year Return
-36.69 %
5 Year Return
-15.88 %

Bio-techne Corp. Stock Fundamentals & Key Indicators

Check Bio-techne Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.0B

EPS (TTM)

1.9075

Dividend Yield

0.43%

Quarterly Earnings Growth YOY

-0.55%

PE Ratio (TTM)

111.43

Industry PE ratio

16.65525641025641

P/B Ratio

111.4348

PEG Ratio

0.71

EBITDA

331.1M

Revenue (TTM)

1.2B

Profit Margin

6.02%

Return On Equity TTM

3.68%

Bio-techne Corp. Stock Valuation

Track how Bio-techne Corp. P/E has moved over time to understand its valuation trends.

Bio-techne Corp. in the last 5 years

  • Overview

  • Trends

Lowest (26.04x)

June 30, 2025

Industry (16.66x)

September 13, 2025

Today (111.43x)

September 13, 2025

Highest (67.99x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 111.43x

Bio-techne Corp. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bio-techne Corp. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$8.0B-15.88%111.436.02%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Bio-techne Corp. Stock including INR - Dollar returns

The Bio-techne Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bio-techne Corp. investment value today

Current value as on today

₹73,801

Returns

₹26,199

(-26.2%)

Returns from Bio-techne Corp. Stock

₹31,338 (-31.34%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Bio-techne Corp. Stock

Based on 19 analysts

BUY

84.21%

Buy

15.79%

Hold

0.00%

Sell

Based on 19 analysts, 84.21% of analysts recommend a 'BUY' rating for Bio-techne Corp.. Average target price of $66.23

Bio-techne Corp. Share Price Target

Get share price movements and forecasts by analysts on Bio-techne Corp..

What analysts predicted

22.59%UPSIDE

Target Price

$66.23

Current Price

$51.27

Analyzed by

19 Analysts

Target

$66.23

Bio-techne Corp. target price $66.23, a slight upside of 22.59% compared to current price of $51.27. According to 19 analysts rating.

Bio-techne Corp. Stock's Interest Amongst Investors

Search interest for Bio-techne Corp. Stock has increased by 77% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:77% versus previous 30 day period

Bio-techne Corp. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
294
301
276
272
303
306
289
297
316
316
Gross Profit
202
204
185
176
205
204
183
193
214
198
Operating Income
80
94
55
38
66
45
39
47
38
-23
EBITDA
105
110
84
77
99
96
73
74
67
6
Interest Expense
1
3
4
4
4
2
2
2
2
2
Depreciation
26
26
28
27
27
28
28
27
27
27
Income Before Tax
80
88
49
33
61
41
40
42
38
-22
Income Tax Expense
9
12
-1
5
12
1
6
7
15
-5
Net Income
70
75
50
27
49
40
33
34
22
-17
Net Profit Margin
23.87%
25.05%
18.41%
10.08%
16.17%
13.26%
11.61%
11.75%
7.14%
-5.58%

Bio-techne Corp. Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
499
563
642
714
738
931
1,105
1,136
1,159
1,219
Gross Profit
336
374
432
473
483
632
756
769
769
790
Operating Income
150
121
136
125
74
149
296
298
206
102
EBITDA
193
181
200
211
373
258
420
460
310
216
Interest Expense
1
7
10
21
19
13
11
11
15
8
Depreciation
-
60
64
78
82
87
101
107
111
109
Income Before Tax
147
113
125
112
276
148
301
338
185
98
Income Tax Expense
43
35
0
15
47
8
38
53
17
25
Net Income
104
77
125
96
229
140
272
285
168
73
Net Profit Margin
20.94%
13.73%
19.49%
13.46%
31.04%
15.08%
24.61%
25.10%
14.50%
6.02%

Bio-techne Corp. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
75
50
27
49
40
33
34
22
-17
Operating Cash Flow
83
59
83
80
75
63
84
41
98
Investing Cash Flow
-4
-154
-23
-16
-8
-21
-5
-8
0
Financing Cash Flow
-24
71
-81
-52
-60
-11
-83
-68
-90
Change in Cash
53
-31
-18
9
11
35
-9
-36
21

Bio-techne Corp. Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
76
126
96
229
139
263
285
168
73
Operating Cash Flow
143
170
181
205
352
325
254
298
287
Investing Cash Flow
-305
-38
-336
27
-243
-96
-265
-203
-35
Financing Cash Flow
189
-99
134
-183
-62
-242
22
-122
-253
Change in Cash
27
30
-21
45
52
-26
8
-28
10

Mutual Funds that own Bio-techne Corp. Stock

Check out the Mutual Funds with significant holdings in Bio-techne Corp..

Funds
Holdings
Shares Held
Motilal Oswal S&P 500 Index Fund Direct Growth
Motilal Oswal S&P 500 Index Fund Direct Growth
0.01553%
1253

Global Institutional Holdings in Bio-techne Corp.

Funds
Holdings
Vanguard Group Inc
11.82%
BlackRock Inc
8.77%
T. Rowe Price Associates, Inc.
7.26%
State Street Corp
4.17%
Morgan Stanley - Brokerage Accounts
3.65%

Bio-techne Corp. News & Key Events

  • img

    Today's Timeline - 21 August

    Thu, 03:33 PM

    -

    Citi upgrades Bio-Techne to Buy from Neutral, raising price target to $70, citing undervaluation and growth potential.

Insights on Bio-techne Corp.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 289.45M → 316.96M (in $), with an average increase of 3.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 159.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 107.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 34.89M → -17.67M (in $), with an average decrease of 106.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TECH stock has moved down by -5.8%

About Bio-techne Corp.

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.
OrganisationBio-techne Corp.
Headquarters614 McKinley Place N.E., Minneapolis, MN, United States, 55413
IndustryHealth Technology
CEOMr. James T. Hippel CPA
E-voting on sharesClick here to vote

Key Management of Bio-techne Corp.

Name

Title

Ms. Cheryl Bethune

Senior VP & Chief Human Resources Officer

Mr. Shane Bohnen

Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer

Dr. Matthew F. McManus M.D., MBA, Ph.D.

President of Diagnostics & Spatial Biology

Mr. Gerry Andros

Vice President of Sales and Marketing

Mr. Martin Wirtz

Senior Vice President of Strategy & Corporate Development

Mr. Luca Cicchetti

Managing Director

Mr. James T. Hippel CPA

Executive VP of Finance & CFO

Mr. William A. Geist

President of Protein Sciences Segment

Dr. Gary J. Latham Ph.D.

VP & CTO

Mr. David Clair C.F.A.

VP of Investor Relations & Corporate Development

FAQs

What is Bio-techne Corp. share price today?

Bio-techne Corp. share price today is $51.27 as on at the close of the market. Bio-techne Corp. share today touched a day high of $52.96 and a low of $50.76.

What is the 52 week high and 52 week low for Bio-techne Corp. share?

Bio-techne Corp. share touched a 52 week high of $80.95 on and a 52 week low of $46.01 on . Bio-techne Corp. stock price today i.e. is closed at $51.27,which is 36.66% down from its 52 week high and 11.43% up from its 52 week low.

What is Bio-techne Corp.'s market capitalisation today?

Bio-techne Corp. market capitalisation is $0.01T as on .

How to invest in Bio-techne Corp. Stock (TECH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bio-techne Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bio-techne Corp. Shares that will get you 0.0293 shares as per Bio-techne Corp. share price of $51.27 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bio-techne Corp. Stock (TECH) from India?

Indian investors can start investing in Bio-techne Corp. (TECH) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Bio-techne Corp. stock (as per the Rupee-Dollar exchange rate as on ). Based on Bio-techne Corp. share’s latest price of $51.27 as on September 13, 2025 at 1:29 am IST, you will get 0.1950 shares of Bio-techne Corp.. Learn more about fractional shares .

What are the returns that Bio-techne Corp. has given to Indian investors in the last 5 years?

Bio-techne Corp. stock has given -15.88% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?